<a href="https://laohu8.com/S/NNVC">NanoViricides Inc.</a> Announces Date for Upcoming Annual Meeting of Stockholders
NanoViricides Inc. has announced that it will hold its Annual Meeting of Stockholders on November 8, 2025, at the Hampton Inn & Suites Stamford in Stamford, Connecticut. During the meeting, shareholders will vote on several key proposals, including the re-election of Anil Diwan as a Class I director for a two-year term, an advisory vote on the compensation of the company's named executive officers, and the ratification and approval of EisnerAmper LLP as the company's independent registered public accounting firm for the 2026 fiscal year. Additionally, shareholders will consider a proposal to adjourn the meeting if necessary to solicit additional proxies, as well as any other business that may properly come before the meeting.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NanoViricides Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-097618), on October 08, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.